Effectiveness, Tolerability and Safety of Rasagiline in Early Parkinson's Disease Patients Not Treated With Levodopa
Clinical trial NCT00203060 · COMPLETED
Trial details
- NCT number
- NCT00203060
- Sponsor
- Teva Neuroscience, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 1997-07-01
- Primary completion
- 2000-07-01
- Enrollment
- 404
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.